81.02
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$82.81
Offen:
$82.11
24-Stunden-Volumen:
10.23M
Relative Volume:
0.77
Marktkapitalisierung:
$202.37B
Einnahmen:
$63.43B
Nettoeinkommen (Verlust:
$16.42B
KGV:
12.48
EPS:
6.49
Netto-Cashflow:
$14.72B
1W Leistung:
-3.65%
1M Leistung:
-3.79%
6M Leistung:
-14.33%
1J Leistung:
-30.07%
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Vergleichen Sie MRK mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MRK
Merck Co Inc
|
81.02 | 206.84B | 63.43B | 16.42B | 14.72B | 6.49 |
![]()
LLY
Lilly Eli Co
|
748.19 | 677.17B | 53.26B | 13.80B | -50.20M | 15.30 |
![]()
JNJ
Johnson Johnson
|
177.40 | 428.83B | 90.62B | 22.66B | 18.18B | 9.35 |
![]()
ABBV
Abbvie Inc
|
217.61 | 385.71B | 58.33B | 3.73B | 18.24B | 2.10 |
![]()
NVS
Novartis Ag Adr
|
123.31 | 240.28B | 53.40B | 13.68B | 16.89B | 6.9231 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
2025-01-08 | Herabstufung | Truist | Buy → Hold |
2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
2024-12-10 | Fortgesetzt | BofA Securities | Buy |
2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
2023-10-20 | Hochstufung | UBS | Neutral → Buy |
2023-07-14 | Eingeleitet | HSBC Securities | Hold |
2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2023-03-06 | Eingeleitet | Jefferies | Buy |
2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
2021-12-17 | Eingeleitet | Goldman | Buy |
2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
2021-12-13 | Herabstufung | UBS | Buy → Neutral |
2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
2021-11-01 | Hochstufung | Argus | Hold → Buy |
2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2021-07-27 | Fortgesetzt | Truist | Buy |
2021-05-20 | Herabstufung | Argus | Buy → Hold |
2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
2020-11-10 | Fortgesetzt | Bernstein | Outperform |
2020-09-29 | Eingeleitet | Berenberg | Hold |
2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2020-02-27 | Eingeleitet | Barclays | Overweight |
2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
2019-07-03 | Eingeleitet | Mizuho | Buy |
2019-05-28 | Eingeleitet | Goldman | Neutral |
2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
2018-10-16 | Bestätigt | Citigroup | Buy |
2018-10-09 | Fortgesetzt | Guggenheim | Buy |
2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Canandaigua National Bank & Trust Co. Purchases 8,282 Shares of Merck & Co., Inc. $MRK - MarketBeat
Canandaigua National Trust Co of Florida Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Quintet Private Bank Europe S.A. Trims Position in Merck & Co., Inc. $MRK - MarketBeat
TruWealth Advisors LLC Has $307,000 Stock Position in Merck & Co., Inc. $MRK - MarketBeat
WBI Investments LLC Buys Shares of 3,395 Merck & Co., Inc. $MRK - MarketBeat
Advisors Capital Management LLC Buys 13,867 Shares of Merck & Co., Inc. $MRK - MarketBeat
Strs Ohio Takes Position in Merck & Co., Inc. $MRK - MarketBeat
MBB Public Markets I LLC Invests $285,000 in Merck & Co., Inc. $MRK - MarketBeat
Intech Investment Management LLC Purchases 628,327 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck’s MK-8527 enables long-acting HIV-1 prevention - BioWorld MedTech
Pharma’s UK dissatisfaction mounts as Merck & Co axes $1.3bn expansion - MarketScreener
Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation - Nasdaq
Sage Capital Advisors llc Purchases New Stake in Merck & Co., Inc. $MRK - MarketBeat
HBW Advisory Services LLC Acquires 6,583 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Jacobs & Co. CA - MarketBeat
Neville Rodie & Shaw Inc. Sells 24,627 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Woodline Partners LP - MarketBeat
Kera Capital Partners Inc. Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Pensionfund Sabic Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Cullen Investment Group LTD. Has $9.53 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Trimmed by Signature Estate & Investment Advisors LLC - MarketBeat
Integrity Alliance LLC. Has $2.26 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
SCS Capital Management LLC Invests $2.21 Million in Merck & Co., Inc. $MRK - MarketBeat
Empowered Funds LLC Acquires 180,118 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Glenview Trust co - MarketBeat
IFM Investors Pty Ltd Sells 3,764 Shares of Merck & Co., Inc. $MRK - MarketBeat
Scientech Research LLC Purchases New Position in Merck & Co., Inc. $MRK - MarketBeat
16,923 Shares in Merck & Co., Inc. $MRK Acquired by Ransom Advisory Ltd - MarketBeat
Plato Investment Management Ltd Purchases 8,468 Shares of Merck & Co., Inc. $MRK - MarketBeat
2 Healthcare Dividend Stocks to Buy and Hold - The Motley Fool
Hedges Asset Management LLC Has $1.09 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Wesbanco Bank Inc. Sells 4,855 Shares of Merck & Co., Inc. $MRK - MarketBeat
Hodges Capital Management Inc. Acquires 14,428 Shares of Merck & Co., Inc. $MRK - MarketBeat
OMNI 360 Wealth Inc. Has $749,000 Stake in Merck & Co., Inc. $MRK - MarketBeat
Leerink Partners Remains Bullish on Merck & Co. (MRK) - Yahoo Finance
Salem Investment Counselors Inc. Cuts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Arvest Investments Inc. Sells 5,313 Shares of Merck & Co., Inc. $MRK - MarketBeat
Geneos Wealth Management Inc. Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Garde Capital Inc. Has $175,000 Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Position Reduced by Harbor Investment Advisory LLC - MarketBeat
Ascent Group LLC Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $1.86 Billion Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Jones Financial Companies Lllp - MarketBeat
Ashton Thomas Private Wealth LLC Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Position Increased by Swedbank AB - MarketBeat
44,586 Shares in Merck & Co., Inc. $MRK Acquired by Bontempo Ohly Capital Mgmt LLC - MarketBeat
AG2R LA Mondiale Gestion D Actifs Makes New $8.39 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
MBL Wealth LLC Sells 3,950 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Reportedly Scraps Research Centre In UK: Retail Sees Stock Rallying To $97.50 - Stocktwits
SageView Advisory Group LLC Sells 7,002 Shares of Merck & Co., Inc. $MRK - MarketBeat
Voleon Capital Management LP Has $6.19 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):